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Abstract
Salmonella and other pathogenic bacteria use the type III secretion system (T3SS) to inject
virulence proteins into human cells to initiate infections. The structural component of the T3SS
contains a needle and a needle tip. The needle is assembled from PrgI needle protomers and the
needle tip is capped with several copies of the SipD tip protein. How a tip protein docks on the
needle is unclear. A crystal structure of a PrgI-SipD fusion protein docked on the PrgI needle
results in steric clash of SipD at the needle tip when modeled on the recent atomic structure of the
needle. Thus, there is currently no good model of how SipD is docked on the PrgI needle tip.
Previously, we showed by NMR paramagnetic relaxation enhancement (PRE) methods that a
specific region in the SipD coiled-coil is the binding site for PrgI. Others have hypothesized that a
domain of the tip protein – the N-terminal α-helical hairpin, has to swing away during the
assembly of the needle apparatus. Here, we show by PRE methods that a truncated form of SipD
lacking the α-helical hairpin domain binds more tightly to PrgI. Further, PRE-based structure
calculations revealed multiple PrgI binding sites on the SipD coiled-coil. Our PRE results together
with the recent NMR-derived atomic structure of the Salmonella needle suggest a possible model
of how SipD might dock at the PrgI needle tip. SipD and PrgI are conserved in other bacterial
T3SSs, thus our results have wider implication in understanding other needle-tip complexes.
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Introduction
Many Gram-negative bacterial pathogens utilize the T3SS to inject virulence proteins into
eukaryotic cells to cause disease [1,2]. The main structural component of the T3SS is the
needle complex, which is a macromolecular structure assembled in the bacterial envelope
from over 20 different proteins and consists of a membrane bound base, an external needle,
a tip, and a translocon (Fig. 1A). In Salmonella, the needle is assembled from the
polymerization of approximately 120 copies of the needle protein PrgI [3-5]. PrgI (80
residues) [6,7] and other T3SS needle protomers [8,9] have α-helical hairpin structures
flanked by flexible tails. At the distal end of the T3SS needle docks a tip complex [10,11],
which in Salmonella is formed by the tip protein SipD (343 residues) [12]. The crystal
structure of SipD [13] and homologs [14,15] show three common structural features: an N-
terminal α-helical hairpin domain, a long central coiled-coil, and a distal domain (Fig. 1B).
Prior to contact with host cell membrane, the T3SS needle apparatus is pre-assembled where
the SipD tip complex is docked at the needle tip but the translocon comprising the
membrane proteins SipB and SipC is still missing [12]. When Salmonella detect eukaryotic
cells, a conformational change occurs at the needle tip in a process that is not yet well
understood that allows the translocon proteins SipB and SipC to transit through the needle
and dock at the SipD tip complex. SipB and SipC form a translocon pore on the host cell
membrane to complete the assembly of the needle apparatus and allow the passage of
effector proteins directly into the host cell [12]. The effectors then modulate host cell
biology for the pathogen’s benefit.
How the tip protein binds to the needle protein is not well understood. Using an intact form
of SipD, we recently showed by PRE that PrgI interacts with a specific region of the SipD
coiled-coil [16]. Others have hypothesized that the α-helical hairpin domain in the tip
proteins functions as a self-chaperone [15] that prevents the tip protein from self-
oligomerizing within the bacterial cytosol. And upon assembly at the needle tip, the α-
helical hairpin domain is not required for interaction with the needle and thereby swings
away [17]. Thus, a truncated form of SipD (here referred to as SipDt, Fig. 1C) lacking the α-
helical hairpin domain should interact with PrgI. To determine how a truncated SipD
interact with PrgI and dock at the needle tip, Lunelli et al. [18] determined the crystal
structure of a PrgI-SipDt fusion protein comprising of PrgI at the N-terminus, a short 5-
residue (GGSGG) linker, and a truncated SipD (residues 127-343) lacking the α-helical
hairpin domain (Fig. 2A). The crystal structure of the PrgI-SipDt fusion protein could be
docked at the needle tip of the model of the needle derived by electron microscopy (EM)
[18]. Since then, however, a seminal contribution from solid-state NMR (ssNMR) by Loquet
et al. [3] showed a completely different orientation of PrgI compared to the EM-derived
atomic models of T3SS needles [4,9,19]. The ssNMR atomic model of the needle places the
N-terminus of needle protomers outside the needle and the C-terminus inside the needle
channel (Fig. 2B, C) [3,20], which is completely opposite to the orientation of needle
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protomers suggested by EM [4,9,19]. When the crystal structure of the PrgI-SipDt fusion
protein [18] is docked on the current model of the PrgI needle, a massive steric clash of
SipD occurs at the needle tip (Fig. 2D). The crystal structure of the PrgI-SipDt fusion protein
is thus incompatible with the current atomic model of the needle and could not be used in
modeling SipD at the needle tip.
Here, we extend our previous PRE studies characterizing the PrgI-SipD interaction by using
a truncated form of SipD lacking the α-helical hairpin. In contrast to the crystallography
results of PrgI-SipDt fusion protein wherein PrgI packs on one contiguous surface of the
SipD coiled-coil [18], our PRE results suggest there are multiple PrgI binding surfaces on
the SipD coiled-coil. Based on our PRE results, we propose a model of SipD docked on the
needle tip without resulting in steric clash of SipD.
Results
PRE of truncated SipD-PrgI interaction
To identify how SipDt (a truncated form of SipD lacking the α-helical hairpin) binds to PrgI,
we used our previous PRE approach [16]. Single time-point PREs were determined for ten
SipDt cysteine mutants spread across the length of the coiled-coil in residues D136, A144,
D147, N155, K173, T303, L318, K324, S331 and E335 (Fig. 3). The structure of SipDt
shown in Fig. 3 is oriented with an arbitrary “top/bottom” or “upper/lower” perspective used
here to describe the various parts of the coiled-coil. Spin labels attached to residues on the
lower half of the coiled-coil on helix α4 (D136, A144 and D147, Fig. 3B) and helix α8
(L318, K324, S331 and E335, Fig. 3), induced strong PRE effect upon titration into PrgI and
peak intensity ratios (Ipar / Idia) were in the range of 0.30 and 0.67 (Fig. 4). D136 at the
extreme bottom of helix α4 exhibited the strongest PRE effect with (Ipar / Idia) ratio of 0.30
(Fig. 4E). On the other hand, when the spin label was attached to K173 (Fig. 4A) or T303
(Fig. 4F), which were located on the upper half of the coiled-coil (Fig. 3), SipDt showed
relatively weaker PRE effect on PrgI with Ipar / Idia ratios at 0.91 and 0.83, respectively. In
line with these, N155 (Fig. 4B) in the middle of helix α4 showed relatively moderate PRE
effect (Ipar / Idia = 0.73). Thus, single time point PREs showed that PrgI mostly interacted
with the lower half of the SipDt coiled-coil spanned by residues D147 to D136 on helix α4
(Fig. 4C-E) and residues L318 to S331 on helix α8 (Fig. 4G-J).
To quantify intermolecular PREs and obtain restraints for PRE-based structure calculations
of the PrgI-SipDt complex, we determined the PRE 1H relaxation rates (Λ2) using the two
time-point method [21]. As the total acquisition time for the two time-point PRE method
was much longer compared to the single time-point method, the two time-point PREs were
only acquired for the four cysteine mutants in positions A144 and D147 on helix α4 and
K324 and E335 on helix α8 that showed the strongest single time-point PREs. As a negative
control, Λ2 were also determined for K173, which showed the weakest single time-point
PRE. Results of two time-point PREs showed that the four spin labels at A144, D147, K324
and E335 showed strong PRE effect, with average Λ2 values of 27.51 s−1, 26 s−1, 32.9 s−1
and 22.5 s−1, respectively (Fig. 5), whereas K173 showed the lowest Λ2 average value of 7.0
s−1.
Rathinavelan et al. Page 3






















Results of PRE structure calculations using Λ2 values from the spin labels at A144, D147,
K324 and E335 as distance restraints revealed that two populations of PrgI were localized
around the lower half of the SipDt coiled-coil region (Fig. 6). One PrgI population was
partly localized at the position previously occupied by the α-helical hairpin facing the lower
half of the SipD coiled-coil (labeled site X in Fig. 6A,B). PRE results suggested that PrgI
binds to SipD at the position previously occupied by the α-helical hairpin. The binding site
X on SipD was not identified as a PrgI binding surface by the crystal structure of the PrgI-
SipDt fusion protein and is a unique contribution from PRE. Our PRE results are the first
direct experimental demonstration that a truncated T3SS tip protein interacts with its
cognate needle protomer at the site previously occupied by the α-helical hairpin, and this
information has a direct bearing on determining how a tip protein docks at the needle tip. A
second PrgI population was localized on another face of the coiled-coil opposite from
binding site X (labeled site Y in Fig. 6A,B). Results of PRE structure calculations therefore
suggested that a truncated SipD could bind simultaneously to two PrgI molecules at two
sites, and that both PrgI binding sites X and Y were located at the lower half of the SipD
coiled-coil and on opposite faces of the coiled-coil (Fig. 6A,B). Another unique contribution
revealed by PRE is that there are two PrgI binding sites on SipD, and this information is also
important in modeling SipD at the needle tip. Results from crystallography [18], ITC [18],
as well as fluorescence polarization [this work] thus far has suggested only one binding site.
Binding site Y (Fig. 6A) overlaps with the PrgI binding site on SipD in the crystal structure
of the PrgI-SipDt fusion protein (Fig. 2A) [18].
PRE-based model of SipD docked at the needle tip
The PRE results regarding the PrgI-SipDt interaction together with the ssNMR-derived
atomic model of the Salmonella needle [3] constrain the possible orientations of SipDt at the
needle tip and thus suggest a possible model of how SipD might dock at the needle tip (Fig.
6C,D,E). In the atomic structure of the Salmonella needle [3], PrgI molecules are arranged
in a spiral symmetry with the PrgI α-helical hairpin slightly titled away from the wall of the
needle. Further, at the needle tip, the PrgI α-helical hairpins are separated from each other
by 25 Å [3], which is the distance between the center of mass of two adjacent PrgI α-helical
hairpins. Because our PRE data suggested that SipDt could interact with two PrgI molecules,
we propose that the SipD central coiled-coil could fit into the gaps between the PrgI α-
helical hairpins at the needle tip. The average distance between the Cα atoms that spans the
coiled-coil region at the bottom of SipD is ~17 Å, which could be easily accommodated
between the two PrgI α-helical hairpins at the needle tip. In this model, the region
corresponding to the SipD N-terminal α-helical hairpin will be splayed outside the needle
(Fig. 6F,G). Consistent with the pentameric state proposed by others [15,17,18], a
pentameric SipD complex could be accommodated at the needle tip (Fig. 6F,G). Further, our
PRE model of how SipD docks at the needle tip reveals the regions of SipD that are exposed
at the needle tip and therefore could be potential sites for interaction with the translocon.
This could be experimentally tested using recombinant SipD and translocon proteins.
Finally, we expect SipD to follow the spiral symmetry of the needle protomers, however,
how this symmetry translates into the translocon remains unknown.
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Biological tests of the model
To test the biological relevance of our PRE-derived PrgI-SipD model, we assayed the effect
of mutations on the PrgI binding site at the SipD coiled-coil region on the ability of
Salmonella to invade cultured human epithelial cells. The ability of Salmonella to invade
eukaryotic cells has been shown to be strictly dependent on SipD function [22]. Point
mutations were introduced in five residues (S148, V157, S313, D320 and V323) located at
the lower half of the SipD coiled-coil at the binding interface with PrgI. The mutations were
designed to alter the bulkiness of the side-chain (S148E, V157K, S313E and V323K) or the
surface electrostatics (S148E, V157K, S313E, D320R and V323K). Results showed that the
S148E mutation did not alter invasiveness (Fig. 7A), suggesting that S148 may not be
crucial for PrgI-SipD interaction. Other mutations, such as point mutations on the lower half
of helix α4 (V157K) and helix α8 (D320R and V323K), significantly decreased
invasiveness. Among these, D320R and V323K located at the bottom of helix α8 showed
only 25% invasiveness, while V157K (on helix α4) and S313E (on helix α8), showed
invasiveness between 50-60% of wild type. We reasoned that point mutations may not cause
large alterations in protein-protein interaction surfaces to drastically affect invasiveness;
hence, double and triple mutations that alter contiguous surfaces were designed. The double
and triple mutations on SipD rendered Salmonella completely non-invasive (Fig. 7A). Thus,
altering the PrgI binding surface on SipD as predicted by the PRE can drastically affect
SipD function and Salmonella invasiveness.
To correlate the observed loss of function of SipD to its binding interaction with PrgI, we
used fluorescence polarization (FP) to quantify the binding affinities of PrgI with the various
SipD mutants. PrgI bound to SipDt with an apparent KD of 108 ± 10 μM (Fig. 7C), however
the dissociation constant of PrgI with SipD could not be determined by FP because it was
too weak as indicated by the FP plot failing to reach saturation (Fig. 7B). Because the FP
assay could be only carried out with the SipDt construct, mutations were introduced in SipDt
and tested for in vitro binding affinity with PrgI. The S148E point mutant, which showed a
wild type phenotype in the invasion assay, displayed a binding affinity (apparent KD of
189± 20 μM) to PrgI similar to SipDt. The other SipD point mutants that showed decreased
invasiveness (S313E, V157K, D320R, and V323K) also showed decreased binding affinities
to PrgI compared to SipDt (Fig. 7B). In contrast, the double and triple mutations that
rendered Salmonella totally non-invasive resulted in Kd that were too weak to be determined
by FP (Fig. 7C). Thus, the decreased in vitro binding affinities between PrgI and SipD
correlated with decreased Salmonella invasion assay.
To further explore the binding of SipD to PrgI in vivo, we used a previously described
surface display immunofluorescence-based assay that specifically detects SipD only when
anchored at the needle tip [12]. In contrast to wild type, the SipD triple mutant (D320R /
D323K / S327R) was not detected at the bacterial surface (Fig. 8 A-C) despite the fact that
this mutant was expressed and secreted by the type III secretion system at wild type levels
(Fig. 8D). It has been previously shown that loss-of-function mutations in the SipD family
of proteins leads to enhance type III secretion. It is thought that the properly positioned SipD
complex at the tip acts as a “lid” that prevents the premature secretion of effector proteins
before contact with cells. We found that a Salmonella strain expressing the SipD triple
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mutant (D320R / D323K / S327R) exhibit enhanced type III secretion equivalent to the
absence of SipD.
Electron microscopy examination of needle complexes obtained from a Salmonella strain
expressing the SipD triple mutant showed that they were properly assembled and exhibited a
normal appearance (Fig. 9). These results confirmed that the phenotypes associated with
mutations in SipD were not the result of gross morphological changes in the needle
complex. Taken together, these results indicate that the SipD triple mutant, which showed a
marked decrease in PrgI binding affinity, was unable to assemble at the tip of the needle
complex in vivo. In other words, the lack of PrgI-SipD interaction observed in the SipD
triple mutant is not due to overt structural defects of the needle complex itself but rather due
to the specific disruption of the PrgI binding surface.
Discussion
An essential step in the assembly of the T3SS needle complex is the anchoring of several
copies of SipD at the tip of the needle. Recently, we showed by using PRE that the
Salmonella PrgI protein binds at the lower half of the SipD coiled-coil [16]. Here, we
extended our results by showing that PrgI binds more tightly to a truncated form of SipD
(termed SipDt here) lacking the N-terminal α-helical hairpin (Fig. 1). This work was
motivated by observations that the N-terminal α-helical hairpin functions mainly as self-
chaperone to the tip protein [15] and that it is partially dispensable for bacterial invasiveness
[23]. Based on structural analysis, others have proposed that the N-terminal α-helical hairpin
may be splayed out to allow the anchoring of SipD at the tip [15,17]. Furthermore, using
isothermal calorimetry, Lunelli et al. [18] showed that the PrgI-SipD interaction could only
be detected when the N-terminal α-helical hairpin was removed from SipD. Understanding
how SipDt interacts with PrgI is important because this information is needed to model how
SipD is docked onto the assembled PrgI needle tip. To this end, Lunelli et al. [18]
determined the crystal structure of a PrgI-SipDt fusion protein and used that structure to
dock SipD on the needle tip. When the PrgI-SipDt fusion protein was docked on the current
model of the PrgI needle [3], however, there was a massive steric clash between SipD
molecules at the needle tip (Fig. 2). Thus the PrgI-SipDt crystal structure could not be used
to dock SipD at the needle tip. We reasoned that the 5-residue linker (with the sequence
GGSGG) between PrgI and SipDt was perhaps too short and artificially constrained PrgI to
SipDt in an orientation that could not be used to dock SipD at the needle tip without
resulting in steric clash of SipD molecules. Here we used PRE methods (Fig. 3-6) to identify
specific regions in the SipDt coiled-coil as the binding sites for PrgI (Fig. 6) and propose an
alternate model (Fig. 6) that did not result in the steric clash of SipD at the needle tip.
Our PRE results identified two binding sites for PrgI on the SipD coiled-coil and suggested
that the SipD coiled-coil region could insert between PrgI protomers at the needle tip (Fig.
6). Our model predicts that upon assembly at the needle tip, the N-terminal α-helical hairpin
of SipD will be splayed outside the needle [15,17]. This scenario is consistent with the
observation that the major epitopes of the Shigella tip protein IpaD that are exposed on the
bacterial surface are in residues 13-121, which correspond to the region encompassing the
N-terminal α-helical hairpin [24]. It should be noted that during the assembly of the needle
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apparatus, the tip protein must pass through a narrow, 25 Å diameter needle channel [4,9],
which at best could only fit two tightly packed α-helices. Hence, the tip protein likely passes
through the channel in a partially unfolded state. Others have also suggested that the tip
protein N-terminal region could swing away to allow the passage of the rest of the tip
protein through the needle channel [14]. Subsequently, upon reaching the needle tip, the
central coiled-coil could be exposed for interaction with the needle protomer.
We have thus shown using PRE methods to characterize the binding interaction of SipD
with PrgI, based on which site-directed mutagenesis could render Salmonella non-invasive
(Fig. 7). The Salmonella invasion assay by itself, however, could not directly link the non-
invasiveness of a particular SipD mutation to defective SipD-PrgI interaction because of the
multifunctional nature of SipD because it binds to other proteins and bile salts and defects in
those interactions could render SipD nonfunctional. Additionally, there are many things that
could go wrong during the assembly of the needle apparatus, which after all is assembled
from over 20 different proteins in a hierarchical and multi-step manner. Thus, we used a
series of experimental approaches to link the non-invasiveness of SipD mutations
specifically to the disruption of the PrgI-SipD binding interface that was identifed by PRE
methods.
We used fluorescence polarization to correlate the relative binding affinities of the PrgI-
SipD interaction with respect to SipD loss of function mutants (Fig. 7). Determination of the
binding affinities between PrgI and SipD is challenging because of the poor solution
behavior of the native forms and weak binding affinities. Currently, there are only two
methods that have been successfully used to measure the binding affinities of PrgI with
SipD – isothermal calorimetry [18], and shown herein, fluorescence polarization. In both
ITC and FP methods, the truncated version of SipD lacking the N-terminal α-helical hairpin
was used because it yielded a measurable binding affinity with PrgI, whereas the intact SipD
construct was beyond the detection limit of fluorescence polarization. The results of
fluorescence polarization (Fig. 7) suggested that the non-invasiveness of the SipD triple
mutants, which were designed to disrupt the PrgI-SipD interaction on the basis of the PRE
results, were due to the decreased binding affinities to PrgI at a molecular level. Further, a
cell-based assay using Flag-tagged SipD demonstrated that the non-invasive triple mutation
(D320R V323K S327R) prevented SipD from localizing on the bacterial surface (Fig. 8).
Electron microscopy showed that Salmonella was able to properly assemble the base and the
PrgI needle itself (Fig. 9), therefore the non-invasive phenotype of the SipD mutants were
due solely to the inability of SipD to bind to PrgI and anchor on the needle tip. Without
SipD anchored at the needle tip, the translocon cannot be assembled rendering Salmonella
incapable of injecting effectors directly into eukaryotic cells and thereby incapable of
invading eukaryotic cells.
The model of SipD at the needle tip is also useful in developing a working model of the
interface beween SipD and the translocon. PrgI and SipD are conserved in other T3SSs, thus
our results will advance understanding of the needle-tip interaction in other bacterial
pathogens.
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Protein expression and purification
The expression and purification of a monomeric form of PrgI lacking the C-terminal five
residues and replaced with a his-tag has been described previously [6]. SipDt (residues
101-343) was subcloned in the NdeI/SalI sites of the expression plasmid pDZ1 [13] and
expressed and purified following similar protocol used for the intact SipD [13]. To eliminate
complications arising from multiple cysteines during the spin labeling, all the SipDt
constructs used in the PRE experiments contained the background C244S mutation. A total
of 10 cysteine point mutations were introduced by PCR in the following residues of SipDt:
D136, A144, D147, N155, K173, T303, L318, K324, S331 and E335 (Fig. 3). These
residues are located along helix α4 and α8 of the central coiled-coil (Fig. 3). All
mutagenesis were confirmed by DNA sequencing. 15N-labeled PrgI and SipDt were
obtained by transforming E. coli BL21(DE) with the appropriate expression plasmid and
growing cells in M9 minimal media with 1 g/L [15N] ammonium chloride as the sole
nitrogen source whereas unlabeled proteins were obtained by growing E. coli in LB
medium.
Fluorescence polarization
For fluorescence polarization (FP), a PrgI double mutant, V65A/V67A, which rendered full-
length PrgI to be soluble and functional [7] was used. A site-directed mutant L31C was used
to attach the fluorophore as follows: PrgI was dialyzed into 1× PBS pH 7.4 with a 10 fold
excess of tris(2-carboxyethyl)phosphine (TCEP) to reduce disulfide bonds for 30 minutes at
25°C. A 20 fold excess of Alexa Fluor 488-C5-Maleimide (Invitrogen) was resuspended in
1× PBS pH 7.4 and added dropwise to the protein solution with mixing and allowed to react
for 3 hours at 25°C in the dark. Excess dye was removed by dialysis in 1× PBS pH 7.4
followed by passage through a centrifugal filter unit with molecular weight cut off of 3 kDa
(Millipore). Increasing concentrations of SipD were titrated into 25 nM PrgI-fluorophore
and FP data were collected at 25°C using a Varian Cary Eclipse Fluorescence
Spectrophotometer. The average of 5 data points was subtracted from a base polarization
value of 25 nM PrgI-fluorophore in 1× PBS pH 7.4 alone. The difference in
millipolarization (ΔmP) was plotted against increasing concentrations of SipD. The FP
binding curve was fitted using the Hill Equation and Origin (OriginLab, Northampton, MA).
Bioassays
Site directed mutations in SipD within the plasmid pRK2 [13] were introduced by PCR and
used to determine the effect of SipD mutations on the ability of Salmonella to invade a
cultured human epithelial cell line Henle 407 (ATCC #CCL6) following protocol described
previously [13]. The S. typhimurium strains (wild type and sipD− knockout) used in the
Salmonella invasion assay have been described previously [13].
For electron microscopy, needle complexes were purified as described elsewhere [5,25].
Purified needle complexes were applied to glow discharged carbon coated Cu-grids and
stained with 2% phosphotungstic acid (PTA), pH 7.0. Images were acquired using a Tecnai
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Biotwin TEM (FEI Company, Hillsboro) at 80 kV using the Morada Soft Imaging system
and a 6 M pixel CCD camera (Olympus, Munster, Germany).
Immunoblotting was used to determine the level of protein expression and secretion of T3SS
proteins and performed as described [12,26] using antibodies specific to the SptP effector
protein and the structural proteins SipB, SipC, InvJ, PrgH, PrgK, InvG, PrgJ, and PrgI.
Immunofluorescence microscopy was used to assay the localization of SipD on the bacterial
surface using mouse monoclonal anti-Flag M2 (Sigma) and a rabbit polyclonal anti-S.
typhimurium lipopolysaccharide (LPS; Difco Laboratories) antibodies as described
elsewhere[12]. S. typhimurium strain with a nonpolar sipD knockout, ΔsipD [22] was
transformed with a plasmid pWSK129 [27] that supplied exogenous internally 3×Flag
tagged sipD (p3×FsipD). The triple mutation (D320R V323K S327R) was introduced in
p3xFsipD.
NMR spectroscopy
NMR data was acquired at 25°C on a Bruker Avance 800 MHz spectrometer equipped with
a cryoprobe, processed with NMRPipe [28] and analyzed using NMRView [29]. The spin
label MTSL (S-(2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl methane-
sulfonothioate, Toronto Research Chemicals) was attached to the SipDt cysteine mutants as
described previously [16]. All the ten SipDt cysteine mutants were 100% spin labeled as
confirmed by electrospray ionization mass spectrometry.
For PRE data acquisition, two 2D proton-nitrogen correlation spectra were acquired for two
samples, one for 15N-labeled PrgI complexed with diamagnetic SipDt, and another for 15N-
labeled PrgI complexed with paramagnetic SipDt. The protein concentrations, buffer
conditions, NMR data acquisition and processing parameters were kept identical for both
samples. Initially, single time-point PREs were determined for the 10 SipDt cysteine
mutants (D136C, A144C, D147C, N155C, K173C, T303C, L318C, K324C, S331C and
E335C) in complex with 15N-labeled PrgI following the PRE method described previously
[16]. In the single time-point PRE method, two identical 2D 1H-15N HSQC [30] spectra
were acquired for 0.6 mM 15N-labeled PrgI complexed with 0.3 mM diamagnetic or
paramagnetic SipDt. Typical acquisition parameters were 8 scans, 18 ppm 15N sweep width
centered at 118 ppm, 216 15N complex points and a recycle delay of 5 sec to ensure that the
magnetization returned to equilibrium before the next scan. Each 2D 1H-15N HSQC
spectrum took about 2.30 hrs to complete. The single time-point PRE for each non-
overlapped PrgI backbone amide peaks was calculated from the peak intensity ratio (Ipar /
Idia).
For the SipDt mutants (D136C, A144C, K324C and E335C) that showed strong single time-
point PREs with PrgI, two time-point PREs [21] were acquired following the method
described previously [16]. As a control, two time-point PREs were also acquired for K173C,
which showed weak single time-point PRE. For acquiring two time-point PREs, the optimal
delay between the two time points [21] was found to be 10 ms. Typically, for a PrgI-SipDt
complex at 1:0.5 molar ratio, the two-time point PRE data was acquired with 108 scans and
18 ppm 15N sweep width centered at 118 ppm. Each 2D 1H-15N HSQC spectra had 2048 1H
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complex points and 300 15N complex points. The total acquisition time was ~23 hrs to
complete the two HSQC spectra for each cysteine mutant. For each non-overlapped peak,
the PRE 1H transverse relaxation rate (Λ2) was determined as described [16] and used as
restraints in structure calculations of the PrgI-SipDt complex using Xplor-NIH [31]. The
protocol for PRE structure calculation has been described earlier [16]. Briefly, each
paramagnetic probe was represented by three conformers with the structure of SipDt fixed.
An ensemble of three conformers was used to represent PrgI and these were allowed to
freely rotate and translate. Jointly refining against intermolecular PREs of A144C, D147C,
K173C, K324C and E335C, 128 structures were calculated and 60 structures were selected
for their lowest PRE Q-factors below 0.35 [21]. All structure figures were rendered using
Pymol [32].
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• SipD interacts with PrgI to form the tip of the type III secretion needle complex.
• PRE methods were used to determine how SipD interacts with PrgI.
• PRE revealed multiple PrgI binding sites on the SipD coiled-coil.
• PRE results allow modeling of SipD at the needle tip.
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Cartoon of T3SS and structure of SipD. (A) Cartoon of the Salmonella T3SS. (B) Crystal
structure of an intact form of SipD (residues 39-343, PDB 3NZZ) [13], and (B) a model of a
truncated form, SipDt (residues 101-343). SipD and SipDt are colored by structural feature
as red (N-terminal α-helical hairpin), green (helix α3), gray (coiled-coil); and cyan (distal
domain).
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Docking of PrgI-SipDt fusion protein at the needle tip. (A) Structure of PrgI-SipDt fusion
protein (PDB 3ZQB, [18]) colored as green (SipDt) and red (PrgI). (B,C) Atomic model of
the Salmonella needle derived by solid-state NMR (PDB 2LPZ, [3]) shown as orthogonal
views. (D) Docking two PrgI-SipDt molecules at the needle tip by superposition of PrgI in
the fusion protein (red) with two adjacent PrgI protomers at the needle tip results in steric
clash of SipDt (green and cyan).
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Location of PRE spin labels on SipDt. (A,B) The PRE spin labels on the SipDt coiled-coil
are depicted as spheres and colored based on weak (yellow), medium (orange), and strong
PRE effect with PrgI. SipDt as depicted here is oriented with an arbitrary “top/bottom” or
“upper/lower” used herein to describe the various parts of the coiled-coil.
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Single time-point PREs of spin labeled SipDt titrated into PrgI. The ten SipDt spin labels are
at position (A) K173, (B) N155, (C) D147, (D) A144, (E) D136, (F) T303, (G) L318, (H)
K324, (I) S331, and (J) E335. The locations of the spin labels on helix α4 and α8 are
indicated by black spheres and the average Ipar/Idia values are indicated on each plot.
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Two time-point PREs. Two time-point Λ2 values of backbone 1HN were acquired for the
SipDt spin labels at positions: (A) A144, (B) D147, (C) K324, (D) E335 and (E) K173.
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Results of PRE structure calculations and model of SipD at the needle tip. (A,B) PRE
structure calculations revealed two binding sites of PrgI around the SipDt coiled-coil. The
PrgI binding sites are labeled site X and site Y and shown as atomic probability maps
around SipDt with the Cα positions of the spin labels shown as red spheres. (C,D, E) Model
of how the SipD coiled-coil will insert in-between the spaces at the needle tip of the
assembled Salmonella needle (PDB 2LPZ). (F,G) Model of full-length SipD at the needle
tip, which could accommodate 5 SipD molecules (colored orange and olive) with the N-
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terminal α-helical hairpin (red) splayed outside the PrgI needle. (F) The question mark
denotes that the conformation of the N-terminal α-helical hairpin is unknown in the
assembled needle-tip complex.
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Decreased Salmonella invasiveness is correlated with decreased PrgI-SipD interaction. (A)
Mutations of SipD residues at the PrgI-SipD binding interface reduced Salmonella
invasiveness. (B,C) The noninvasive SipD mutations abrogated the SipDt-PrgI interaction as
determined by fluorescence polarization.
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A non-invasive SipD triple mutant (D320R/V323K/S327R) failed to be displayed on the
bacterial surface. (A) Salmonella sipD− knockout strain probed with antibodies to
lipopolysaccharide (red) and Flag-tag (green) transformed with plasmid that supplied no
SipD (left panel); Flag-tagged SipD (middle panel), Flag-tagged mutant SipD (right panel).
(B) Protein expression and secretion of SipD and other T3SS proteins were not affected as
probed by immunoblotting.
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Needle complex assembly and stability is not affected by mutations in SipD. (A) Electron
micrographs of purified needle complex from a Salmonella sipD− knockout strain
transformed with plasmid that supplied no SipD (left panel); Flag-tagged SipD (middle
panel), Flag-tagged mutant SipD (right panel). (B) Purified needle complexes were probed
with antibodies against proteins that form the needle complex (InvG, PrgH, PrgK, PrgI, and
PrgJ).
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